Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

N/ACompletedNCT02207855

Joseph D. Tobias21 enrolled

Overview

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Anesthesia

Interventions

ChloroprocaineDRUG

Eligibility

Sex: ALLMax age: 2 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Neonates and infants who have received chloroprocaine for epidural anesthesia. Exclusion Criteria: * None

Locations (1)

Nationwide Children's Hospital

Columbus, Ohio, United States

Outcomes

Primary Outcomes

Pain score

Time frame: Every 6 hours for 72 hours

Secondary Outcomes

Pain medicine consumption

Time frame: Every 6 hours for 72 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.